The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements

RW Buchanan, J Kreyenbuhl, DL Kelly… - Schizophrenia …, 2010 - academic.oup.com
In light of the large number of studies published since the 2004 update of Schizophrenia
Patient Outcomes Research Team psychopharmacological treatment recommendations, we …

Assessment and management of agitation in psychiatry: expert consensus

M Garriga, I Pacchiarotti, S Kasper… - The world journal of …, 2016 - Taylor & Francis
Background Psychomotor agitation is associated with different psychiatric conditions and
represents an important issue in psychiatry. Current recommendations on agitation in …

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death

PM Haddad, IM Anderson - Drugs, 2002 - Springer
Sudden unexpected deaths have been reported with antipsychotic use since the early
1960s. In some cases the antipsychotic may be unrelated to death, but in others it appears to …

A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia

A Breier, K Meehan, M Birkett, S David… - Archives of General …, 2002 - jamanetwork.com
Background An intramuscular (IM) formulation of olanzapine has been developed because
there are no rapid-acting IM atypical antipsychotic drugs currently available in the United …

Joint BAP NAPICU evidence-based consensus guidelines for the clinical management of acute disturbance: de-escalation and rapid tranquillisation

MX Patel, FN Sethi, TRE Barnes, R Dix… - Journal of …, 2018 - ingentaconnect.com
The British Association for Psychopharmacology and the National Association of Psychiatric
Intensive Care and Low Secure Units developed this joint evidence-based consensus …

Systematic reviews of assessment measures and pharmacologic treatments for agitation

SL Zeller, RW Rhoades - Clinical therapeutics, 2010 - Elsevier
Background: Agitation is a common behavioral emergency associated with high risk of injury
to patients and health care professionals. There are a wide variety of approaches to …

Haloperidol plus promethazine for psychosis‐induced aggression

G Huf, J Alexander, P Gandhi… - Cochrane Database of …, 2016 - cochranelibrary.com
Haloperidol plus promethazine for psychosis‐induced aggression - Huf, G - 2016 | Cochrane
Library Skip to Content Cookies Our site uses cookies to improve your experience. You can …

Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethazine

TREC Collaborative Group - Bmj, 2003 - bmj.com
Objective To compare two widely used drug treatments for people with aggression or
agitation due to mental illness. Design Pragmatic, randomised clinical trial. Setting Three …

[HTML][HTML] Race, quality of care, and antipsychotic prescribing practices in psychiatric emergency services

SP Segal, JR Bola, MA Watson - Psychiatric services (Washington …, 1996 - ncbi.nlm.nih.gov
Objective The study examined whether the prescription practices of clinicians in psychiatric
emergency services differed for African-American patients. Prescription of antipsychotic …

Rapid tranquillisation of violent or agitated patients in a psychiatric emergency setting: pragmatic randomised trial of intramuscular lorazepam v. haloperidol plus …

J Alexander, P Tharyan, C Adams, T John… - The British Journal of …, 2004 - cambridge.org
BackgroundThe pharmacological management of violence in people with psychiatric
disorders is under-researched. AimsTo compare interventions commonly used for …